Sanjivani Paranteral Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "163.90",
    "chg": -2.95,
    "chgp": "-1.77%",
    "dir": -1,
    "prev_price": "166.85",
    "mcapval": "223.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE860D01013",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "12.01 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjiv.Parant. Sees Revision in Market Assessment Amidst Valuation and Performance Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivparant-downgraded-to-sell-by-marketsmojo-amid-valuation-and-performance-concerns-3744055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanjivParant_mojoScore_3744055.png",
        "date": "2025-12-03 11:08:04",
        "description": "Sanjiv.Parant., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed review of the company’s quality, valuation, financial trends, and technical indicators, highlighting challenges in sustaining growth amid a demanding market environment."
      },
      {
        "title": "Why is Sanjiv.Parant. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sanjivparant-fallingrising-3742321",
        "imagepath": "",
        "date": "2025-12-03 00:26:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>On 02-Dec, Sanjivani Paranteral Ltd’s shares gained ₹5.45, or 2.8%, closing at ₹200. The stock has outperformed its sector by 2.79% on the day and has recorded gains for five consecutive sessions, delivering a 9.17% return over the past week. This contrasts sharply with the broader Sensex, which rose a modest 0.65% during the same period. The stock’s intraday high touched ₹202.95, marking a 4.32% increase, while the low was ₹190.20, down 2.24%, indicating some volatility within the session.</p>\n<p>Despite this recent upswing, the stock’s performance over longer horizons remains subdued. Year-to-date, it has declined by 47.64%, significantly underperforming the Sensex’s 8.96% gain. Over the past year, the stock has fallen 31.62%, whi..."
      },
      {
        "title": "Sanjivani Paranteral Q2 FY26: Revenue Decline and Margin Pressure Signal Challenging Quarter",
        "link": "https://www.marketsmojo.com/news/result-analysis/sanjivani-paranteral-q2-fy26-revenue-decline-and-margin-pressure-signal-challenging-quarter-3718777",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanjivaniParant_quaterlyResult_3718777.png",
        "date": "2025-11-18 12:39:36",
        "description": "Sanjivani Paranteral Ltd., a WHO-GMP certified pharmaceutical company specialising in injectables and oral solids, reported a challenging Q2 FY26 with net profit declining to ₹1.64 crores, down 5.20% quarter-on-quarter and 28.70% year-on-year. The micro-cap pharmaceutical player, with a market capitalisation of ₹223.00 crores, faced headwinds from contracting revenues and compressed margins during the September 2025 quarter. The stock has reacted negatively to the results, trading at ₹181.85 as of November 18, 2025, down 3.86% and significantly below its 52-week high of ₹396.95."
      },
      {
        "title": "Is Sanjiv.Parant. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sanjivparant-overvalued-or-undervalued-3709675",
        "imagepath": "",
        "date": "2025-11-18 08:18:42",
        "description": "As of 17 November 2025, the valuation grade for Sanjiv.Parant. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued based on its high PE ratio of 30.96, a price to book value of 6.08, and an EV to EBITDA of 23.36. In comparison to its peers, Sun Pharma has a higher PE ratio of 36.69, while Cipla appears more attractive with a PE of 22.81.\n\nGiven these ratios and the overall market context, Sanjiv.Parant.'s valuation seems excessive, particularly when considering its recent stock performance, which has underperformed the Sensex significantly over the past year, with a decline of 37.72% compared to the Sensex's gain of 9.50%. This further reinforces the conclusion that the company is overvalued in its current state...."
      },
      {
        "title": "Why is Sanjiv.Parant. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sanjivparant-fallingrising-3708106",
        "imagepath": "",
        "date": "2025-11-17 21:23:14",
        "description": "As of 17-Nov, Sanjivani Paranteral Ltd is experiencing a decline in its stock price, currently at Rs. 188.00, which reflects a decrease of Rs. 13.25 or 6.58%. The stock has recently hit a new 52-week low of Rs. 170 and has been underperforming its sector by 6.86%. Over the past week, the stock has fallen by 9.62%, and it has shown a significant year-to-date decline of 50.79%. The stock has been trading below its moving averages across various time frames, indicating a bearish trend. Additionally, it has seen high volatility today with an intraday fluctuation of 7%, and while there has been a rise in investor participation, the overall performance remains weak.\n\nIn the broader market context, the Sensex has shown a positive return of 1.69% over the past week, contrasting sharply with Sanjivani Paranteral's negative performance. This divergence highlights the stock's struggles relative to the overall market. ..."
      },
      {
        "title": "Sanjivani Paranteral Hits New 52-Week Low at Rs. 170",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-hits-new-52-week-low-at-rs-170-3707126",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanjivaniParant_priceRelatedfactors_3707126.png",
        "date": "2025-11-17 10:59:39",
        "description": "Sanjivani Paranteral has reached a new 52-week low, reflecting a notable decline in its stock performance. The company has underperformed its sector and experienced consecutive losses, while also showing high volatility. Despite these challenges, it maintains strong management efficiency and healthy long-term growth in net sales and operating profit."
      },
      {
        "title": "Sanjivani Paranteral Hits New 52-Week Low at Rs. 170",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-hits-new-52-week-low-at-rs-170-3707121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanjivaniParant_priceRelatedfactors_3707121.png",
        "date": "2025-11-17 10:59:14",
        "description": "Sanjivani Paranteral has hit a new 52-week low, reflecting a significant downturn in its stock performance. The company has underperformed its sector and experienced high volatility, trading below key moving averages. Despite these challenges, it maintains strong management efficiency and increased promoter confidence in its future."
      },
      {
        "title": "Sanjivani Paranteral Hits 52-Week Low at Rs. 170 Amid Market Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-hits-52-week-low-at-rs-170-amid-market-gains-3707120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanjivaniParant_priceRelatedfactors_3707120.png",
        "date": "2025-11-17 10:59:14",
        "description": "Sanjivani Paranteral has hit a new 52-week low of Rs. 170, reflecting a notable decline amid broader market gains. The stock has underperformed its sector and is trading below key moving averages, raising concerns despite some positive indicators like increased promoter confidence and growth in net sales and operating profit."
      },
      {
        "title": "Sanjivani Paranteral Hits New 52-Week Low at Rs. 170",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-hits-new-52-week-low-at-rs-170-3707118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanjivaniParant_priceRelatedfactors_3707118.png",
        "date": "2025-11-17 10:59:08",
        "description": "Sanjivani Paranteral has reached a new 52-week low, reflecting a significant downturn in its stock performance. The company has underperformed its sector and experienced consecutive declines. Despite these challenges, it maintains strong management efficiency and has reported healthy long-term growth in net sales and operating profit."
      }
    ],
    "total": 182,
    "sid": "328426",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Jan-2026",
      "details": "Certificate under regulation 74(5) for the Quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Dec-2025",
      "details": "Closure of Trading Window for the Quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "05-Dec-2025",
      "details": "Regularisation of Mr. Basant Shrivastava as an Independent Director",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanjiv.Parant. Sees Revision in Market Assessment Amidst Valuation and Performance Concerns

2025-12-03 11:08:04

Sanjiv.Parant., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed review of the company’s quality, valuation, financial trends, and technical indicators, highlighting challenges in sustaining growth amid a demanding market environment.

Why is Sanjiv.Parant. falling/rising?

2025-12-03 00:26:56

Recent Price Performance and Market Context On 02-Dec, Sanjivani Paranteral Ltd’s shares gained ₹5.45, or 2.8%, closing at ₹200. The stock has outperformed its sector by 2.79% on the day and has recorded gains for five consecutive sessions, delivering a 9.17% return over the past week. This contrasts sharply with the broader Sensex, which rose a modest 0.65% during the same period. The stock’s intraday high touched ₹202.95, marking a 4.32% increase, while the low was ₹190.20, down 2.24%, indicating some volatility within the session. Despite this recent upswing, the stock’s performance over longer horizons remains subdued. Year-to-date, it has declined by 47.64%, significantly underperforming the Sensex’s 8.96% gain. Over the past year, the stock has fallen 31.62%, whi...

Sanjivani Paranteral Q2 FY26: Revenue Decline and Margin Pressure Signal Challenging Quarter

2025-11-18 12:39:36

Sanjivani Paranteral Ltd., a WHO-GMP certified pharmaceutical company specialising in injectables and oral solids, reported a challenging Q2 FY26 with net profit declining to ₹1.64 crores, down 5.20% quarter-on-quarter and 28.70% year-on-year. The micro-cap pharmaceutical player, with a market capitalisation of ₹223.00 crores, faced headwinds from contracting revenues and compressed margins during the September 2025 quarter. The stock has reacted negatively to the results, trading at ₹181.85 as of November 18, 2025, down 3.86% and significantly below its 52-week high of ₹396.95.

Is Sanjiv.Parant. overvalued or undervalued?

2025-11-18 08:18:42

As of 17 November 2025, the valuation grade for Sanjiv.Parant. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued based on its high PE ratio of 30.96, a price to book value of 6.08, and an EV to EBITDA of 23.36. In comparison to its peers, Sun Pharma has a higher PE ratio of 36.69, while Cipla appears more attractive with a PE of 22.81. Given these ratios and the overall market context, Sanjiv.Parant.'s valuation seems excessive, particularly when considering its recent stock performance, which has underperformed the Sensex significantly over the past year, with a decline of 37.72% compared to the Sensex's gain of 9.50%. This further reinforces the conclusion that the company is overvalued in its current state....

Why is Sanjiv.Parant. falling/rising?

2025-11-17 21:23:14

As of 17-Nov, Sanjivani Paranteral Ltd is experiencing a decline in its stock price, currently at Rs. 188.00, which reflects a decrease of Rs. 13.25 or 6.58%. The stock has recently hit a new 52-week low of Rs. 170 and has been underperforming its sector by 6.86%. Over the past week, the stock has fallen by 9.62%, and it has shown a significant year-to-date decline of 50.79%. The stock has been trading below its moving averages across various time frames, indicating a bearish trend. Additionally, it has seen high volatility today with an intraday fluctuation of 7%, and while there has been a rise in investor participation, the overall performance remains weak. In the broader market context, the Sensex has shown a positive return of 1.69% over the past week, contrasting sharply with Sanjivani Paranteral's negative performance. This divergence highlights the stock's struggles relative to the overall market. ...

Sanjivani Paranteral Hits New 52-Week Low at Rs. 170

2025-11-17 10:59:39

Sanjivani Paranteral has reached a new 52-week low, reflecting a notable decline in its stock performance. The company has underperformed its sector and experienced consecutive losses, while also showing high volatility. Despite these challenges, it maintains strong management efficiency and healthy long-term growth in net sales and operating profit.

Sanjivani Paranteral Hits New 52-Week Low at Rs. 170

2025-11-17 10:59:14

Sanjivani Paranteral has hit a new 52-week low, reflecting a significant downturn in its stock performance. The company has underperformed its sector and experienced high volatility, trading below key moving averages. Despite these challenges, it maintains strong management efficiency and increased promoter confidence in its future.

Sanjivani Paranteral Hits 52-Week Low at Rs. 170 Amid Market Gains

2025-11-17 10:59:14

Sanjivani Paranteral has hit a new 52-week low of Rs. 170, reflecting a notable decline amid broader market gains. The stock has underperformed its sector and is trading below key moving averages, raising concerns despite some positive indicators like increased promoter confidence and growth in net sales and operating profit.

Sanjivani Paranteral Hits New 52-Week Low at Rs. 170

2025-11-17 10:59:08

Sanjivani Paranteral has reached a new 52-week low, reflecting a significant downturn in its stock performance. The company has underperformed its sector and experienced consecutive declines. Despite these challenges, it maintains strong management efficiency and has reported healthy long-term growth in net sales and operating profit.

View All News